statements

Continental Chemicals Ltd.

BSE: 506935

Sector: Information Technology

Industry Group: IT - Software

Industry: Software Products

57.59+0.0 (+0.00%)

21 Oct, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Continental Chemicals Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	0.19	0.31	0.19	0.48	0.44	0.42	0.22	0.26	0.25
Gross Profit	0.19	0.31	0.19	0.48	0.44	0.42	0.22	0.26	0.25
Gross Margin	100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0
Total Operating Expenses	1.01	0.99	0.76	0.93	0.96	0.93	1.05	1.05	1.10
Operating Profit	-0.82	-0.67	-0.57	-0.45	-0.52	-0.51	-0.83	-0.79	-0.85
Operating Margin	-428.6	-215.9	-292.1	-94.5	-118.3	-120.2	-373.6	-310.5	-332.7
Financing Income/(Expense) - Net	0.00	-0.05	-0.04	-0.04	-0.03	-0.04	-0.04	-0.04	-0.04
Profit before Taxes	0.30	0.16	0.17	0.07	0.27	0.61	0.48	0.59	0.55
Income Taxes	-0.04	0.08	0.02	0.01	0.03	0.09	0.05	0.08	0.07
Profit after Tax	0.34	0.08	0.14	0.06	0.25	0.52	0.44	0.51	0.48
PAT Margin	175.9	25.0	73.8	12.5	56.8	122.3	196.0	200.6	190.0
EPS - Basic - ex Extraordinary Items	3.37	0.49	0.64	0.27	1.11	2.30	1.94	2.28	2.15
EPS - Diluted - ex Extraordinary Items	3.37	0.49	0.64	0.27	1.11	2.30	1.94	2.28	2.15
EBIT	-0.82	-0.67	-0.57	-0.45	-0.52	-0.51	-0.83	-0.79	-0.85
EBITDA	-0.75	-0.59	-0.48	-0.36	-0.43	-0.44	-0.76	-0.67	-0.72
EBITDA Margin	-393.8	-188.0	-247.4	-75.8	-98.0	-103.4	-340.9	-263.7	-282.7

Balance Sheet

Abridged

Understanding Balance Sheet

Continental Chemicals Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	0.25	1.96	2.20	2.33	2.55	2.75	3.12	3.74
Long-Term Investments	-	-	-	-	-	0.60	0.60	0.60
Property Plant & Equipment - Net	1.80	1.95	1.86	1.78	1.70	1.90	1.99	1.97
Total Non-Current Assets	2.64	2.72	2.65	2.59	2.52	2.82	2.92	2.89
Total Assets	2.89	4.69	4.86	4.92	5.07	5.57	6.04	6.64
Total Current Liabilities	0.80	0.82	0.88	0.88	0.78	0.87	0.90	0.96
Long Term Debt	0.14	0.21	0.15	0.14	0.15	0.03	0.03	0.03
Total Non-Current Liabilities	0.22	0.29	0.23	0.23	0.22	0.11	0.11	0.13
Total Liabilities	1.02	1.11	1.12	1.11	1.00	0.98	1.01	1.09
Total Shareholders' Equity	1.88	3.58	3.74	3.81	4.07	4.59	5.03	5.55
Total Equity	1.88	3.58	3.74	3.81	4.07	4.59	5.03	5.55
Total Liabilities & Equity	2.89	4.69	4.86	4.92	5.07	5.57	6.04	6.64

Cash Flow

Abridged

Understanding Cash Flow Statement

Continental Chemicals Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	0.30	0.18	0.31	0.11	0.35	0.61	0.45	0.68
Working Capital - Increase/(Decrease)	-0.31	0.02	-0.75	0.05	-0.44	0.44	-0.39	-0.62
Net CF from Operating Activities	-0.01	0.20	-0.44	0.16	-0.09	1.06	0.06	0.06
Capital Expenditures - Net	0.01	0.23	0.00	0.01	0.00	0.27	0.17	0.10
Net CF from Investing Activities	-0.01	-0.23	0.00	-0.01	0.00	-0.87	-0.17	-0.10
Stock - Issuance/(Retirement) - Net	-	1.25	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	0.00	0.07	-0.06	-0.06	0.00	-0.12	-	0.00
Net Cash Flow from Financing Activities	0.00	1.69	-0.06	-0.06	0.00	-0.12	-	0.00
Free Cash Flow to Equity	-0.03	0.04	-0.50	0.08	-0.09	0.67	-0.11	-0.04
Free Operating CF net dividend	-0.02	-0.02	-0.44	0.14	-0.10	0.79	-0.11	-0.05
Free Operating CF	-0.02	-0.02	-0.44	0.14	-0.10	0.79	-0.11	-0.05

Business Segment Analysis

Continental Chemicals Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Continental Chemicals Ltd.

Regional Segment Analysis

Continental Chemicals Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Continental Chemicals Ltd.

Historical Segment Analysis

Track how Continental Chemicals Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Continental Chemicals Ltd.

Frequently Asked Questions

What is the revenue of Continental Chemicals Ltd.?

The latest trailing twelve month revenue of Continental Chemicals Ltd. is ₹ 0.25 Cr, reflecting a 1-year growth of 10.84% and a 3-year CAGR of -21.04%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Continental Chemicals Ltd.?

The latest trailing twelve month net profit (PAT) of Continental Chemicals Ltd. is ₹ 0.48 Cr, with a 3-year earnings CAGR of 20.28%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Continental Chemicals Ltd.?

The trailing twelve month EBITDA of Continental Chemicals Ltd. is approximately ₹ -0.85 Cr (based on an operating margin of -332.69%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Continental Chemicals Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Continental Chemicals Ltd. is 2.15. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Continental Chemicals Ltd.?

The debt-to-equity ratio of Continental Chemicals Ltd. stands at 0.01. The interest coverage ratio is -19.51x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Continental Chemicals Ltd.?

The estimated book value per share of Continental Chemicals Ltd. is 24.67 (derived from a P/B ratio of 2.33 and market price of ₹ 57.59), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Continental Chemicals Ltd.?

The trailing twelve month operating cash flow of Continental Chemicals Ltd. is ₹ 0.06 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Continental Chemicals Ltd. report consolidated or standalone financials?

Continental Chemicals Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.